3Settimana
•
11
•
3Settimana
@RealMichaelScott $MO and $PM have outperformed $BATS in recent years, in my opinion they have the stronger brands (such as Marlboro). Where the journey in tobacco substitutes is heading is still unclear to me, but all three seem to be well positioned. If I had to choose one, it would probably be Philip Morris. Considering that Philip Morris is active worldwide ex USA (probably the strongest and most promising tobacco market in the world), there is no way around Altria. So the logical conclusion for me is that if you decide against Bats for Philip Morris, you should also invest at least a small proportion in Altria. In addition to being the market leader in the USA, Altria also has interesting investments/shareholdings in $ABI and in cannabis companies. Many key figures are also positive, high cash flow and the dividend is also covered.
•
11
•3Settimana
@Levinson_G On the one hand, $MO is of course a strong company, but on the other hand it generates almost 100% of its sales in the USA. I see $PM and $BATS as being much more broadly positioned. You mentioned the US weighting in your portfolio in another post. $BATS is active in India, for example, and therefore in a large growth market.
I don't think you're really doing much wrong with all three companies, but I see it the same way as you: $PM is the strongest, but for me $BATS comes next and then $MO. Of course, this is just my subjective opinion, but it's all the more interesting to hear your opinion explained.
I don't think you're really doing much wrong with all three companies, but I see it the same way as you: $PM is the strongest, but for me $BATS comes next and then $MO. Of course, this is just my subjective opinion, but it's all the more interesting to hear your opinion explained.
•
22
•